Thin-layer chromatography quality control method for bran-fried gordon euryale seed formula granules and application of thin-layer chromatography quality control method

Through the thin-layer chromatography quality control method, starch components were discarded and tested in combination with reference materials and control medicinal materials. A specific expansion agent combination was used to solve the problem of starch interference in the detection of granules of bran fried water chestnut formula, and improved the detection accuracy and quality control. comprehensiveness.

CN118914441AActive Publication Date: 2024-11-08BEIJING KANGRENTANG PHARMA
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411122442.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-15
Publication Date
2024-11-08
Estimated Expiration
2044-08-15

AI Technical Summary

Technical Problem

In the prior art, the thin-layer detection method of bran fried water chestnut formula particles is disturbed by starch components, which leads to difficulty in identifying authenticity and falsehood, making it difficult to effectively distinguish between bran fried water chestnut formula particles and other formula particles with starch auxiliary materials such as maltodextrin.

Method used

The thin-layer chromatography quality control method was used to mix the sample to be tested with the alcohol, discard the starch components, and conduct thin-layer chromatography detection with reference materials and control medicinal materials, using mixed solutions of trichloromethane, ethyl formate and formic acid as the expansion. Reduce interference from starch components and improve detection accuracy.

Benefits of technology

It effectively reduces interference with starch ingredients, improves the accuracy of the test results, and can distinguish between bran fried water chestnut formula particles from other formula particles, avoids false negative problems, and ensures the comprehensiveness and accuracy of quality control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118914441A_ABST
    Figure CN118914441A_ABST
Patent Text Reader

Abstract

The invention provides a thin-layer chromatography quality control method and application of bran-fried gordon euryale seed formula granules, and the thin-layer chromatography quality control method comprises the following steps: (1) mixing and refluxing a sample to be detected and alcohol to obtain a test solution; (2) mixing the bran-fried gordon euryale seed reference medicinal material with water and refluxing to obtain a reference medicinal material solution; (3) mixing a reference substance with alcohol to obtain a reference substance solution; and (4) performing thin-layer chromatography detection on the test solution, the reference medicinal material solution and the reference substance solution, and judging the quality of the to-be-detected sample according to a detection result. According to the method provided by the invention, starch components are abandoned, the interference of the starch components is effectively reduced, and the accuracy of a detection result is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of quality control of traditional Chinese medicines, and specifically relates to a thin layer chromatography quality control method for bran-fried gorgon fruit formula granules and an application thereof, and in particular relates to a thin layer chromatography quality control method for bran-fried gorgon fruit formula granules with low interference and an application thereof. Background Art

[0002] Gorgon fruit is the dried mature kernel of Euryale ferox Salisb, a plant of the Nymphaeaceae family. Gorgon fruit has a long history of medicinal use in my country and is a famous traditional medicinal material. This product is mild in nature, sweet and astringent in taste, and enters the spleen and kidney meridians. It is a tonic Chinese herbal medicine. Its effects are to nourish the kidney and consolidate the essence, tonic the spleen and stop diarrhea, and to remove dampness and stop leukorrhea. It is used for spermatorrhea, nocturnal emission, frequent urination, chronic diarrhea due to spleen deficiency, leukorrhea, and leukorrhea. The 2020 edition of the Pharmacopoeia stipulates that the testing items include medicinal material properties, identification, and inspection.

[0003] Fried Gorgon Fruit with Gluten is a processed product of Gorgon Fruit, with a bright yellow or yellow surface and a slight aroma. Fried Gorgon Fruit with Gluten is warm in nature, and has enhanced spleen-tonifying and astringent effects. It is suitable for patients with spleen deficiency and those with more deficiency than excess. Fried Gorgon Fruit with Gluten has similar effects to Fried Gorgon Fruit, both of which are better at tonifying the spleen and astringent effects. It is mainly used for diarrhea due to spleen deficiency and spermatorrhea due to weak sperm gate due to kidney deficiency, and can also be used for leucorrhea due to spleen deficiency.

[0004] At present, the thin layer method involving bran-fried gorgon fruit is basically based on the pharmacopoeia method, and the components detected in the pharmacopoeia method of bran-fried gorgon fruit water extract are basically starch components, but in the process of preparing bran-fried gorgon fruit formula granules, maltodextrin and other starch-containing auxiliary materials are artificially added, which interferes with the detection and makes it difficult to identify the authenticity of bran-fried gorgon fruit formula granules. Therefore, how to provide a thin layer detection method for bran-fried gorgon fruit formula granules that can effectively reduce starch interference has become an urgent problem to be solved. Summary of the invention

[0005] In view of the deficiencies of the prior art, the object of the present invention is to provide a thin layer chromatography quality control method for bran-fried gorgon fruit formula granules and its application, in particular to provide a thin layer chromatography quality control method for bran-fried gorgon fruit formula granules with low interference and its application. The method provided by the present invention abandons starch components, effectively reduces the interference of starch components, and improves the accuracy of the detection results.

[0006] In order to achieve the purpose of the invention, the present invention adopts the following technical solutions:

[0007] On the one hand, the present invention provides a thin layer chromatography quality control method for bran-fried Euryale ferox formula granules, the thin layer chromatography quality control method comprising the following steps:

[0008] (1) mixing the sample to be tested with alcohol and refluxing to obtain a test solution;

[0009] (2) mixing the bran-fried Euryale ferox seed control medicinal material with water and refluxing to obtain a control medicinal material solution;

[0010] (3) mixing the reference substance with alcohol to obtain a reference substance solution;

[0011] (4) Perform thin layer chromatography on the test sample solution, reference medicinal material solution and reference substance solution, and judge the quality of the sample according to the test results.

[0012] Steps (1), (2), and (3) are performed in no particular order.

[0013] The above method processes the sample and then performs thin layer chromatography detection in combination with reference substances and reference medicinal materials, discards starch components in the detection, effectively reduces the interference of starch components, and improves the accuracy of the detection results.

[0014] Preferably, the alcohol comprises ethanol.

[0015] Preferably, the solid-liquid ratio of the sample to be tested to the alcohol solution in step (1) is 1:(10-20) g / mL, for example 1:10 g / mL, 1:11 g / mL, 1:12 g / mL, 1:13 g / mL, 1:14 g / mL, 1:15 g / mL, 1:16 g / mL, 1:17 g / mL, 1:18 g / mL, 1:19 g / mL or 1:20 g / mL, but is not limited to the above-listed values, and other values ​​not listed within the above numerical range are equally applicable.

[0016] Preferably, the solid-liquid ratio of the stir-fried Euryale ferox reference medicinal material to water in step (2) is 1:(10-20) g / mL, for example 1:10 g / mL, 1:11 g / mL, 1:12 g / mL, 1:13 g / mL, 1:14 g / mL, 1:15 g / mL, 1:16 g / mL, 1:17 g / mL, 1:18 g / mL, 1:19 g / mL or 1:20 g / mL, but is not limited to the above-listed values, and other values ​​not listed within the above numerical range are equally applicable.

[0017] Preferably, the reference substance in step (3) comprises gallic acid and / or linoleic acid.

[0018] Preferably, the reference substance in step (3) comprises gallic acid and linoleic acid.

[0019] Preferably, in the thin layer chromatography detection in step (4), the developing solvent is a mixed solution of chloroform, ethyl formate and formic acid.

[0020] The above-mentioned specific developing agent combination can effectively analyze the characteristic spots in the test samples and reference substances, reduce the interference of starch components, and improve the accuracy of the test results.

[0021] Preferably, in the mixed solution of chloroform, ethyl formate and formic acid, the volume ratio of chloroform, ethyl formate and formic acid is (4-6):(4-6):(0.8-1.2), wherein the number of chloroform can be 4, 4.5, 5, 5.5 or 6, the number of ethyl formate can be 4, 4.5, 5, 5.5 or 6, and the number of formic acid can be 0.8, 0.9, 1, 1.1 or 1.2, but are not limited to the values ​​listed above, and other values ​​not listed within the above numerical range are also applicable.

[0022] On the other hand, the present invention also provides the application of the above-mentioned thin layer chromatography quality control method in the detection of bran-fried Euryale ferox formula granules.

[0023] Compared with the prior art, the present invention has the following beneficial effects:

[0024] The invention provides a thin layer chromatography quality control method for bran-fried gorgon fruit formula granules. The method comprises the following steps: processing a sample and then performing thin layer chromatography detection in combination with a reference substance and a reference medicinal material, wherein starch components are discarded in the detection, and interference of starch auxiliary materials such as maltodextrin artificially added in the prior art on the detection is effectively reduced. The bran-fried gorgon fruit formula granules and other formula granules with starch auxiliary materials such as maltodextrin added can be effectively distinguished, and the false negative problem in the prior method is avoided, and the accuracy of the detection result is improved. Furthermore, the reference substance and the reference medicinal material are used for multi-faceted and multi-angle comparison, so that the bran-fried gorgon fruit formula granules can be detected more comprehensively and effectively, and the comprehensiveness and accuracy of the quality control are guaranteed. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 It is a thin layer identification chromatogram of the bran-fried Euryale ferox reference medicinal material and the bran-fried Euryale ferox formula granules in the durability and specificity investigation in Example 1;

[0026] Figure 2 It is a thin layer identification chromatogram of the reference substance, the bran-fried Euryale ferox reference medicinal material and the bran-fried Euryale ferox formula granules in the durability and specificity investigation in Example 1;

[0027] Figure 3 This is a thin layer identification chromatogram of the bran-fried Euryale ferox formula granules at room temperature (26° C.) in Example 1;

[0028] Figure 4 This is a thin layer identification chromatogram of the bran-fried Euryale ferox formula granules at low temperature (6° C.) in Example 1;

[0029] Figure 5 This is a thin layer identification chromatogram of the bran-fried Euryale ferox formula granules under high humidity (relative humidity 88%) in Example 1;

[0030] Figure 6This is a thin layer identification chromatogram of the bran-fried Euryale ferox formula granules under low humidity (relative humidity 23%) in Example 1;

[0031] Figure 7 This is a thin layer identification chromatogram of the bran-fried Euryale ferox formula granules using Merck silica gel G plate in Example 1;

[0032] Figure 8 This is a thin layer identification chromatogram of the bran-fried Euryale ferox formula granules using the silica gel G plate of Tianjin Sili Da Technology Co., Ltd. in Example 1;

[0033] Fig. 9 This is a thin layer identification chromatogram of the bran-fried Euryale ferox formula granules using the silica gel G plate of Yantai Huayang New Materials Technology Co., Ltd. in Example 1;

[0034] Fig.10 It is the thin layer identification chromatogram of 3 batches of bran fried Euryale ferox formula granule samples in Example 1;

[0035] Fig.11 is a thin layer identification chromatogram of the bran-fried Euryale ferox formula granule sample in Example 2;

[0036] Fig.12 is a thin layer identification chromatogram of the bran-fried Euryale ferox formula granule sample in Example 3;

[0037] Fig.13 is a thin layer identification chromatogram of the bran-fried Euryale ferox formula granule sample in Example 4;

[0038] Fig.14 is a thin layer identification chromatogram of the bran-fried Euryale ferox formula granule sample in Example 5;

[0039] Fig.15 is a thin layer identification chromatogram of the bran-fried Euryale ferox formula granule sample in Example 6;

[0040] Fig.16 It is the thin layer identification chromatogram in comparative example 1;

[0041] Fig.17 This is the thin layer identification chromatogram in Comparative Example 2. DETAILED DESCRIPTION

[0042] The technical solution of the present invention is further described below by specific implementation methods. It should be understood by those skilled in the art that the embodiments are only to help understand the present invention and should not be regarded as specific limitations of the present invention.

[0043] In the following example, the sources of raw materials and consumables are as follows:

[0044] Test drugs: reference medicinal materials of fried gorgon fruit with bran (batch number: K145YC01, homemade), fried gorgon fruit formula granules with bran (batch number: K145CP01, K145CP06, K145CP11), linoleic acid (batch number: 111622-202105, China Food and Drug Inspection Institutes); gallic acid reference substance (batch number: 110831-201906, China Food and Drug Inspection Institutes).

[0045] Reagents: Ethyl formate, formic acid, chloroform, and anhydrous ethanol were of analytical grade, and water was ultrapure water.

[0046] Consumables: Merck silicone G plate (specification: 200×200 mm; batch number: 1.05721.0001), Yantai Huayang New Material Technology Co., Ltd. silicone G plate (model: HSG-G, specification: 100×200 mm, batch number: 20210309), Tianjin Silida Technology Co., Ltd. silicone G plate (model: HSG-G, specification: 100×200 mm, batch number: 20210707).

[0047] Example 1

[0048] This embodiment provides a thin layer chromatography quality control method for bran-fried Euryale ferox formula granules, and the specific steps are as follows:

[0049] Preparation of the test solution: Take 2.0 g of the granules of fried Euryale ferox with bran, grind them into powder, add 50 mL of anhydrous ethanol, heat and reflux for 30 minutes, filter, and concentrate the filtrate to 2 mL as the test solution.

[0050] Preparation of control medicinal material solution: Take 12.0 g of the control medicinal material of fried Euryale ferox with bran, add 200 mL of water, reflux for 30 minutes, centrifuge (4000 rpm, 20 minutes), take the supernatant to a 100 mL conical flask and concentrate to dryness under reduced pressure, add 60 mL of anhydrous ethanol to the residue, heat and reflux for 30 minutes, filter, and concentrate the filtrate to 2 mL as the control medicinal material solution.

[0051] Preparation of reference solution: Take linoleic acid reference substance and add anhydrous ethanol to make a solution containing 0.5 mg per 1 mL as the reference solution.

[0052] Take gallic acid reference substance and add anhydrous ethanol to make a solution containing 0.2 mg per 1 mL as the reference substance solution.

[0053] Preparation of negative control solution: According to the proportion of excipients in the formula of fried gorgon fruit granules with bran, take an appropriate amount of maltodextrin and prepare it in the same way as the test sample solution as the negative control solution.

[0054] Durability and specificity inspection

[0055] Investigation on different spotting amounts and specificity of test and control medicinal material solutions

[0056] 15μL, 20μL, 25μL, 30μL of bran-fried Euryale ferox reference medicinal material solution, 10μL, 15μL, 20μL, 25μL of bran-fried Euryale ferox formula granules (batch number: K145CP01) test solution, 3μL, 4μL, 5μL of linoleic acid reference solution, 3μL, 4μL, 5μL of gallic acid reference solution, were respectively applied on silica gel G plate (silica gel G plate of Yantai Huayang New Materials Technology Co., Ltd.), chloroform-ethyl formate-formic acid (volume ratio 5:5:1) was used as the developing agent, developed, taken out, dried, sprayed with phosphomolybdic acid test solution, heated at 105°C for 3min until the spots were clearly colored, and inspected under sunlight. In the chromatogram of the test sample, spots of the same color appeared at the corresponding positions of the chromatograms of the reference substance and the reference medicinal material.

[0057] The experimental results are as follows Figure 1 (1. bran-fried gorgon fruit control medicinal material (15μL); 2. bran-fried gorgon fruit control medicinal material (20μL); 3. bran-fried gorgon fruit control medicinal material (25μL); 4. bran-fried gorgon fruit control medicinal material (30μL); 5. bran-fried gorgon fruit formula granules (K145CP01) test sample (10μL); 6. bran-fried gorgon fruit formula granules (K145CP01) test sample (15μL); 7. bran-fried gorgon fruit formula granules (K145CP01) test sample (20μL); 8. bran-fried gorgon fruit formula granules (K145CP01) test sample (25μL)) and Figure 2 (1. Linoleic acid reference substance (3μL); 2. Linoleic acid reference substance (4μL); 3. Linoleic acid reference substance (5μL); 4. Gallic acid reference substance (3μL); 5. Gallic acid reference substance (4μL) 6. Gallic acid reference substance (5μL) 7. Fried Gorgon Fruit reference medicinal material (20μL); 8. Fried Gorgon Fruit formula granules (K145CP01) test sample (15μL)).

[0058] Depend on Figure 1-2 It can be seen that the thin layer chromatographic spots of the test samples with different spotting amounts are all clear, without tailing phenomenon, the spot separation is good, all can present relatively clear spots, and the number does not change, indicating that fine-tuning of the spotting amount has no effect on the detection; the thin layer chromatographic spots of the control medicinal materials with different spotting amounts are all clear, without tailing phenomenon, the spot separation is good, all can present relatively clear spots, and the number does not change, indicating that fine-tuning of the spotting amount has no effect on the detection.

[0059] Different temperature investigation

[0060] ①Normal temperature inspection

[0061] Experimental condition control method: Normal temperature refers to 10-30℃, relative humidity is controlled at 45%-75%, put the spotted thin layer plate into the developing cylinder, then add the developing agent, seal and place for 20 minutes (saturated), develop, take out, dry, spray with phosphomolybdic acid test solution, heat at 105℃ for 3min until the spots are clearly colored, and inspect under sunlight. In the chromatogram of the test sample, spots of the same color appear at the corresponding positions of the chromatograms of the reference sample and the reference medicinal material.

[0062] Experimental operation method: 15μL of maltodextrin negative solution, 15μL of test solution of bran-fried gorgon seed formula granules (batch number: K145CP01), 20μL of bran-fried gorgon seed control medicinal material solution, 4μL of linoleic acid reference substance, and 4μL of gallic acid reference substance were respectively taken and spotted on the same silica gel G plate. Chloroformane-ethyl formate-formic acid (volume ratio 5:5:1) was used as the developing agent. The plate was developed at room temperature (temperature: 26°C, relative humidity: 60%). The plate was taken out, dried, sprayed with phosphomolybdic acid test solution, heated at 105°C for 3 minutes until the spots were clearly colored, and inspected under sunlight. In the chromatogram of the test sample, spots of the same color appeared at the corresponding positions of the chromatograms of the reference sample and the control medicinal material. The experimental results are shown in Figure 3 (1. Linoleic acid reference substance (4μL); 2. Gallic acid reference substance (4μL); 3. Fried Gorgon Fruit with Glutinous Rice Bran Reference Medicinal Material (20μL); 4. Fried Gorgon Fruit with Glutinous Rice Bran Formula Granule (K145CP01) Test Sample (15μL); 5. Maltodextrin Negative Solution (15μL)).

[0063] ② Low temperature (4-10℃) inspection

[0064] Experimental condition control method: The temperature is set to 4℃ in the refrigerator and controlled at 4-10℃. The spotted thin layer plate is placed in a developing tank, and then the developing agent is added. It is sealed and placed for 20 minutes (saturated), developed, taken out, dried, sprayed with phosphomolybdic acid test solution, heated at 105℃ for 3 minutes until the spots are clearly colored, and inspected under sunlight. In the chromatogram of the test sample, spots of the same color appear at the corresponding positions of the chromatograms of the reference sample and the reference medicinal material.

[0065] Experimental operation method: 15μL of maltodextrin negative solution, 15μL of test solution of bran-fried gorgon seed formula granules (batch number: K145CP01), 20μL of bran-fried gorgon seed control medicinal material solution, 4μL of linoleic acid reference substance, and 4μL of gallic acid reference substance were respectively taken and spotted on the same silica gel G plate, and chloroformate-ethyl formate-formic acid (volume ratio 5:5:1) was used as the developing agent. The plate was developed at low temperature (temperature: 6°C, relative humidity: 70%), taken out, dried, sprayed with phosphomolybdic acid test solution, heated at 105°C for 3 minutes until the spots were clearly colored, and inspected under sunlight. In the chromatogram of the test sample, spots of the same color appeared at the corresponding positions of the chromatograms of the reference sample and the control medicinal material. The experimental results are shown in Figure 4(1. Linoleic acid reference substance (4μL); 2. Gallic acid reference substance (4μL); 3. Fried Gorgon Fruit with Glutinous Rice Bran Reference Medicinal Material (20μL); 4. Fried Gorgon Fruit with Glutinous Rice Bran Formula Granule (K145CP01) Test Sample (15μL); 5. Maltodextrin Negative Solution (15μL)).

[0066] Depend on Figure 3-4 It can be seen that the experimental results show that in the chromatogram of the test sample of the formula granules of fried gorgon fruit with bran, spots of the same color can be seen at the corresponding positions in the chromatogram of the reference medicinal material of fried gorgon fruit with bran, and the chromatographic spot separation effect is good.

[0067] Investigation of different humidity (high humidity, low humidity)

[0068] High humidity (relative humidity 88%) experimental condition control method: This experiment investigates the effect of relative humidity 88% on thin layer identification. Measure 108mL of sulfuric acid, add 1000mL of water, mix and prepare. Add to the dryer), put the spotted thin layer plate into the developing cylinder of the dryer, then add the developing agent, seal and place for 20 minutes (saturated), develop, take out, spray with phosphomolybdic acid test solution, heat at 105℃ for 3min until the spots are clearly colored, and inspect under sunlight. In the chromatogram of the test sample, spots of the same color appear at the corresponding positions of the chromatograms of the reference sample and the reference medicinal material.

[0069] Experimental operation method: 15μL of maltodextrin negative solution, 15μL of the test solution of bran-fried gorgon seed formula granules (batch number: K145CP01), 20μL of bran-fried gorgon seed control medicinal material solution, 4μL of linoleic acid reference substance, and 4μL of gallic acid reference substance were respectively taken and spotted on the same silica gel G plate. Chloroformane-ethyl formate-formic acid (volume ratio 5:5:1) was used as the developing agent. The plate was developed in high humidity (temperature: 26°C, relative humidity: 88%). The plate was taken out, dried, sprayed with phosphomolybdic acid solution, and heated at 105°C for 3 minutes until the spots were clearly colored. The plates were inspected under sunlight. In the chromatogram of the test sample, spots of the same color appeared at the corresponding positions of the chromatograms of the reference sample and the control medicinal material. The experimental results are shown in Figure 5 (1. Linoleic acid reference substance (4μL); 2. Gallic acid reference substance (4μL); 3. Fried Gorgon Fruit with Glutinous Rice Bran Reference Medicinal Material (20μL); 4. Fried Gorgon Fruit with Glutinous Rice Bran Formula Granule (K145CP01) Test Sample (15μL); 5. Maltodextrin Negative Solution (15μL)).

[0070] Low humidity (relative humidity 23%) experimental condition control method: This experiment examines the effect of relative humidity 23% on thin layer identification. Add dry beads into the desiccator, put the spotted thin layer plate into the developing cylinder, then add the developing agent, seal and place for 20 minutes (saturated), develop, take out, dry, spray with phosphomolybdic acid test solution, heat at 105℃ for 3 minutes until the spots are clearly colored, and inspect under sunlight. In the chromatogram of the test sample, spots of the same color appear at the corresponding positions of the chromatograms of the reference sample and the reference medicinal material.

[0071] Experimental operation method: 15μL of maltodextrin negative solution, 15μL of the test solution of bran-fried gorgon fruit formula granules (batch number: K145CP01), 20μL of bran-fried gorgon fruit control medicinal material solution, 4μL of linoleic acid reference substance, and 4μL of gallic acid reference substance were respectively taken and spotted on the same silica gel G plate, and chloroformate-ethyl formate-formic acid (volume ratio 5:5:1) was used as the developing agent. The plate was developed in low humidity (temperature: 26°C, relative humidity: 23%), taken out, dried, sprayed with phosphomolybdic acid test solution, heated at 105°C for 3 minutes until the spots were clearly colored, and inspected under sunlight. In the chromatogram of the test sample, spots of the same color appeared at the corresponding positions of the chromatograms of the reference sample and the control medicinal material. The experimental results are shown in Figure 6 (1. Linoleic acid reference substance (4μL); 2. Gallic acid reference substance (4μL); 3. Fried Gorgon Fruit with Glutinous Rice Bran Reference Medicinal Material (20μL); 4. Fried Gorgon Fruit with Glutinous Rice Bran Formula Granule (K145CP01) Test Sample (15μL); 5. Maltodextrin Negative Solution (15μL)).

[0072] Depend on Figure 5-6 It can be seen that under high humidity and low humidity conditions, the chromatogram of the test sample of the bran-fried gorgon fruit formula granules showed spots of the same color at the corresponding position of the chromatogram of the bran-fried gorgon fruit control medicinal material, and the chromatographic spot separation effect was good. The experimental results show that humidity has no significant effect on the thin layer identification of the bran-fried gorgon fruit formula granules, and the thin layer identification method has good durability to humidity.

[0073] Investigation of thin-layer boards from different manufacturers

[0074] (1) Merck silica gel G plate (specification: 200×200 mm; batch number: 1.05721.0001)

[0075] (2) Silica gel G plate (model: HSG-G, specification: 100×200mm, batch number: 20210309) produced by Yantai Huayang New Materials Technology Co., Ltd.

[0076] (3) Tianjin Silida Technology Co., Ltd. Silicone G plate (model: HSG-G, specification: 100×200mm, batch number: 20210707)

[0077] Take one piece of each of the above brands of prefabricated plates and operate according to the above method. Respectively aspirate 15μL of maltodextrin negative solution, 15μL of the test solution of bran-fried gorgon fruit formula granules (batch number: K145CP01), 20μL of bran-fried gorgon fruit control medicinal material solution, 4μL of linoleic acid reference substance, and 4μL of gallic acid reference substance, and spot them on the same silica gel G plate. Use chloroform-ethyl formate-formic acid (volume ratio 5:5:1) as the developing agent, develop, take out, dry, spray with phosphomolybdic acid test solution, heat at 105°C for 3 minutes until the spots are clearly colored, and inspect under sunlight. In the chromatogram of the test sample, spots of the same color appear at the corresponding positions of the chromatograms of the reference sample and the control medicinal material. The experimental results are shown in Figure 7-9 (1. Linoleic acid reference substance (4μL); 2. Gallic acid reference substance (4μL); 3. Fried Gorgon Fruit with Glutinous Rice Bran Reference Medicinal Material (20μL); 4. Fried Gorgon Fruit with Glutinous Rice Bran Formula Granule (K145CP01) Test Sample (15μL); 5. Maltodextrin Negative Solution (15μL)).

[0078] Depend on Figure 7-9 It can be seen that the separation effects of silica gel G plates of the three brands are similar. The chromatogram of the test sample of the formula granules of fried gorgon fruit with bran and bran shows spots of the same color at the corresponding positions of the chromatograms of the reference medicinal materials and reference samples of the fried gorgon fruit with bran and bran. The experimental results show that thin layer plates from different manufacturers have no significant effect on the thin layer identification of the formula granules of fried gorgon fruit with bran and bran. The durability of this thin layer identification method is good and is suitable for this experimental conditions.

[0079] The above method was used to perform TLC identification on three batches of bran-fried Euryale ferox granules. The results were as follows: Fig.10 As shown (1. linoleic acid reference substance (4μL); 2. gallic acid reference substance (4μL); 3. bran-fried gorgon fruit reference medicinal material (20μL); 4. bran-fried gorgon fruit formula granules (K145CP01) test sample (15μL); 5. bran-fried gorgon fruit formula granules (K145CP06) test sample (15μL); 6. bran-fried gorgon fruit formula granules (K145CP11) test sample (15μL)).

[0080] from Fig.10 It can be found that this method can effectively identify the granules of fried bran and Euryale ferox, with good durability and specificity, clear spots and good separation effect.

[0081] Example 2

[0082] This embodiment provides a thin layer chromatography quality control method for bran-fried Euryale ferox formula granules. The specific steps are consistent with those in Example 1 except that the developing solvent is a chloroform-ethyl formate mixed solution (volume ratio of 5:5).

[0083] Results Fig.11(1. Gallic acid reference substance (4μL); 2. Linoleic acid reference substance (4μL); 3. Fried Gorgon Fruit with Glutinous Rice Bran Reference Material (20μL); 4. Fried Gorgon Fruit with Glutinous Rice Bran Formula Granule (K145CP01) Test Sample (15μL); 5. Maltodextrin Negative Solution (15μL)). The Rf value of the gallic acid spot was low, the development system was not suitable, the development effect was poor, and the developing agent needed to be replaced.

[0084] Example 3

[0085] This embodiment provides a thin layer chromatography quality control method for bran-fried Euryale ferox formula granules. The specific steps are consistent with those in Example 1 except that the developing solvent is a chloroform-formic acid mixed solution (volume ratio 5:1).

[0086] Results Fig.12 (1. Gallic acid reference substance (4μL); 2. Linoleic acid reference substance (4μL); 3. Fried Gorgon Fruit with Glutinous Rice Bran as reference substance (20μL); 4. Fried Gorgon Fruit with Glutinous Rice Bran as formula granules (K145CP01) as test substance (15μL); 5. Maltodextrin negative solution (15μL)). The gallic acid spots and linoleic acid spots did not develop well, and the development effect was poor, so the developing agent needed to be replaced.

[0087] Example 4

[0088] This embodiment provides a thin layer chromatography quality control method for bran-fried Euryale ferox formula granules. The specific steps are consistent with those in Example 1 except that the developing solvent is a mixed solution of ethyl formate-formic acid (volume ratio of 5:1).

[0089] Results Fig.13 (1. Gallic acid reference substance (4μL); 2. Linoleic acid reference substance (4μL); 3. Fried Gorgon Fruit with Glutinous Rice Bran Reference Material (20μL); 4. Fried Gorgon Fruit with Glutinous Rice Bran Formula Granule (K145CP01) Test Sample (15μL); 5. Maltodextrin Negative Solution (15μL)). The gallic acid spot had a higher Rf value, while the linoleic acid spot reached the front of the solvent, resulting in poor development effect and the need to replace the developing agent.

[0090] Example 5

[0091] This embodiment provides a thin layer chromatography quality control method for bran-fried Euryale ferox formula granules. The specific steps are consistent with those in Example 1 except that the developing solvent is a mixed solution of chloroform-ethyl formate-formic acid (volume ratio of 5:10:1).

[0092] Results Fig.14(1. Gallic acid reference substance (4μL); 2. Linoleic acid reference substance (4μL); 3. Fried Gorgon Fruit with Glutinous Rice Bran as reference substance (20μL); 4. Fried Gorgon Fruit with Glutinous Rice Bran as formula granules (K145CP01) as test substance (15μL); 5. Maltodextrin negative solution (15μL)). The linoleic acid spots were scattered during the development process. The development system was not suitable, the development effect was poor, and the developing agent needed to be replaced.

[0093] Example 6

[0094] This embodiment provides a thin layer chromatography quality control method for bran-fried Euryale ferox formula granules. The specific steps are consistent with those in Example 1 except that the developing solvent is a mixed solution of chloroform-ethyl formate-formic acid (volume ratio of 10:5:1).

[0095] Results Fig.15 (1. Gallic acid reference substance (4μL); 2. Linoleic acid reference substance (4μL); 3. Fried Gorgon Fruit with Glutinous Rice Bran Reference Material (20μL); 4. Fried Gorgon Fruit with Glutinous Rice Bran Formula Granule (K145CP01) Test Sample (15μL); 5. Maltodextrin Negative Solution (15μL)). The Rf value of the gallic acid spot was low, the development system was not suitable, the development effect was poor, and the developing agent needed to be replaced.

[0096] Comparative Example 1

[0097] This comparative example provides a thin layer chromatography quality control method for bran-fried Euryale ferox formula granules, and the specific steps are as follows:

[0098] Take 2g of the powder of the granules of fried Euryale ferox with bran, add 30mL of dichloromethane, ultrasonically treat for 15 minutes, filter, evaporate the filtrate to dryness, and add 2mL of ethyl acetate to the residue to dissolve it as the test solution. Take another 2g of Euryale ferox as a reference medicinal material and prepare a reference medicinal solution in the same way. According to the thin layer chromatography method (General Rules 0502 of the 2020 Edition of the Chinese Pharmacopoeia), 10μL of each of the above two solutions were taken and spotted on the same silica gel G thin layer plate, respectively, with n-hexane-acetone (volume ratio of 5:1) as the developing agent, develop, take out, dry, spray with 10% ethanolic sulfuric acid solution, and heat at 105°C until the spots are clearly colored. In the chromatogram of the test sample, spots of the same color appear at the corresponding position of the chromatogram of the control medicinal material. See the results. Fig.16 (1. Linoleic acid reference substance (4μL); 2. Fried Euryale Glutinosa medicinal material with bran (15μL); 3. Fried Euryale Glutinosa formula granules with bran (15μL); 4. Maltodextrin negative test substance (15μL). The left picture is the picture under sunlight, and the right picture is the picture under ultraviolet light).

[0099] It can be clearly seen by the pharmacopoeia method that after water extraction, the color of the formula granules becomes lighter than that of the medicinal material spots, and some spots are lost, but the linoleic acid spots still exist when observed at 365nm, proving that there are still linoleic acid spots in the formula granules. However, the spots of maltodextrin and formula granules in this development system are basically the same. In subsequent tests, it is impossible to prove whether the sample is a bran-fried gorgon seed formula granule or other formula granules with added excipients (maltodextrin). It is impossible to control the quality of the bran-fried gorgon seed formula granules. It is necessary to change the development system, discard the maltodextrin interference spots, and ensure quality control.

[0100] Comparative Example 2

[0101] This comparative example provides a thin layer chromatography quality control method for bran-fried Euryale ferox formula granules, and the specific steps are as follows:

[0102] Take an appropriate amount of bran-fried Euryale ferox formula granules, grind them, take 1g, add 30mL of methanol, ultrasonically treat for 30 minutes, filter, evaporate the filtrate, add 20mL of water to the residue to dissolve, shake and extract with ethyl acetate twice, 20mL each time, combine the ethyl acetate solution, evaporate to dryness, and add 1mL of methanol to the residue to dissolve as the test solution. Take another 10g of bran-fried Euryale ferox control medicinal material, add 100mL of water, boil for 30 minutes, filter, evaporate the filtrate, and make the control medicinal material solution from "add 30mL of methanol..." in the same way. According to the thin layer chromatography method (General Rules 0502 of the 2020 Edition of the Chinese Pharmacopoeia), take 20μL of each of the above two solutions and spot them on the same silica gel G thin layer plate, use toluene-ethyl formate-formic acid (10:8:1) as the developing agent, develop, take out, dry, spray with 5% phosphomolybdic acid ethanol test solution, and heat at 105°C until the spots are clearly colored. In the chromatogram of the test sample, spots of the same color appear at the corresponding positions in the chromatogram of the control medicinal material. Fig.17 (1. Linoleic acid; 2. Gallic acid; 3. Formula granules of fried water chestnuts with bran).

[0103] The developing solvent in this method contains toluene, which is too toxic, and other spots are blurred and have poor separation.

[0104] The applicant declares that the present invention illustrates the thin layer chromatography quality control method and application of the bran-fried Euryale ferox formula granules of the present invention through the above-mentioned embodiments, but the present invention is not limited to the above-mentioned embodiments, that is, it does not mean that the present invention must rely on the above-mentioned embodiments to be implemented. Those skilled in the art should understand that any improvement of the present invention, equivalent replacement of the raw materials of the product of the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.

[0105] The preferred embodiments of the present invention are described in detail above. However, the present invention is not limited to the specific details in the above embodiments. Within the technical concept of the present invention, a variety of simple modifications can be made to the technical solution of the present invention, and these simple modifications all belong to the protection scope of the present invention.

[0106] It should also be noted that the various specific technical features described in the above specific embodiments can be combined in any suitable manner without contradiction. In order to avoid unnecessary repetition, the present invention will not further describe various possible combinations.

Claims

1. A thin layer chromatography quality control method for bran-fried Euryale ferox formula granules, characterized in that: The thin layer chromatography quality control method comprises the following steps: (1) mixing the sample to be tested with alcohol and refluxing to obtain a test solution; (2) mixing the bran-fried Euryale ferox seed control medicinal material with water and refluxing to obtain a control medicinal material solution; (3) mixing the reference substance with alcohol to obtain a reference substance solution; (4) subjecting the test sample solution, the reference medicinal material solution, and the reference substance solution to thin layer chromatography, and judging the quality of the test sample based on the test results; Steps (1), (2), and (3) are performed in no particular order.

2. The thin layer chromatography quality control method according to claim 1, characterized in that: The alcohol includes ethanol.

3. The thin layer chromatography quality control method according to claim 1 or 2, characterized in that: In step (1), the solid-liquid ratio of the sample to be tested to the alcohol solution is 1:(10-20) g / mL.

4. The thin layer chromatography quality control method according to any one of claims 1 to 3, characterized in that: The solid-liquid ratio of the bran-fried Euryale ferox reference medicinal material to water in step (2) is 1:(10-20) g / mL.

5. The thin layer chromatography quality control method according to any one of claims 1 to 4, characterized in that: The reference substance in step (3) includes gallic acid and / or linoleic acid.

6. The thin layer chromatography quality control method according to claim 5, characterized in that: The reference substance in step (3) includes gallic acid and linoleic acid.

7. The thin layer chromatography quality control method according to any one of claims 1 to 6, characterized in that: In the thin layer chromatography detection of step (4), the developing solvent is a mixed solution of chloroform, ethyl formate and formic acid.

8. The thin layer chromatography quality control method according to claim 7, characterized in that: In the mixed solution of chloroform, ethyl formate and formic acid, the volume ratio of chloroform, ethyl formate and formic acid is (4-6):(4-6):(0.8-1.2).

9. Application of the thin layer chromatography quality control method according to any one of claims 1 to 8 in the detection of bran-fried Euryale ferox formula granules.

Citation Information

Patent Citations

  • Food containing traditional Chinese medicine composition and capable of tonifying consumptive disease and qi as well as detection and preparation method of food

    CN118077883A